Related Experiment Video
Updated: Jul 14, 2025
10:43
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
3.4K
TP53 Mutations in Esophageal Squamous Cell Carcinoma.
Leqi Zhong1,2, Hongmu Li1,2, Wuguang Chang1,2
1Department of Thoracic Oncology, Sun Yat-Sen University Cancer Center, 510060 Gunagzhou, Guangdong, China.
Frontiers in Bioscience (Landmark Edition)
|October 5, 2023
Summary
Mutations in the TP53 tumor suppressor gene are common in esophageal squamous cell carcinoma (ESCC), driving tumor development and resistance to treatment. Understanding mutant TP53 is crucial for developing new targeted therapies for ESCC.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Esophageal cancer, particularly esophageal squamous cell carcinoma (ESCC), is a major health concern, especially in East Asia.
- Multiple genetic abnormalities drive ESCC development, invasion, and metastasis, leading to poor patient outcomes.
- TP53 tumor suppressor gene mutations are frequent in ESCC, appearing early in carcinogenesis.
Purpose of the Study:
- To investigate the role of mutant TP53 in the development and progression of esophageal squamous cell carcinoma.
- To highlight the impact of TP53 mutations on treatment resistance and patient prognosis.
- To underscore the need for novel therapeutic strategies targeting mutant TP53 in ESCC.
Main Methods:
- Review of genetic abnormalities in esophageal cancer development.
- Analysis of the functional consequences of TP53 mutations in ESCC.
- Examination of current therapeutic approaches and future directions for targeting mutant TP53.
Main Results:
- TP53 mutations are prevalent in ESCC, even in early stages.
- Mutant TP53 disrupts normal p53 network functions, promoting tumor growth, resistance to radiation and chemotherapy, and immune suppression.
- These disruptions contribute to ESCC progression, metastasis, and poor prognosis.
Conclusions:
- Mutant TP53 plays a critical role in esophageal squamous cell carcinoma pathogenesis and poor outcomes.
- Targeting mutant TP53 is essential for improving survival rates in ESCC patients.
- Further research into mutant TP53 is needed to develop innovative, targeted therapies.
Related Concept Videos
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:21Barrett Esophagus-I: Introduction
107
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
107
01:21Barrett Esophagus-II: Clinical Manifestations and Management
172
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
172
01:30Esophageal Strictures-I: Introduction
119
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
119
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K